FEATURED COMPANIES
- Abbott Laboratories
- Roche Diagnostics
- Sysmex Corporation
In China, the in vitro diagnostic industry has evolved since the 1980s, and now the key players are manufacturing from single and straight forward products to complete industrial chains. The 21st century brought a rapid development in China's IVD industry, where all the tools such as reagents and instruments are produced in-house. The increasing number of test volumes related to clinical chemistry, immunoassay, haematology, coagulation and microbiology are in high demand. They are acting as a catalysing role for the growth of the China IVD industry. According to this report, China's In Vitro Diagnostics Market will be USD 22.3 Billion by 2026.
The major growth drivers for China's IVD industry are increasing demand from the middle class for high-quality healthcare products, and rising incidences of lifestyle diseases. In China, there has been massive expenditure in every healthcare segment in the areas of pharmaceuticals, medical devices, and traditional Chinese medicines. The significant barriers for China's IVD industry is the lagging by local manufacturers in the adoption of advanced technology.
In October 2020, Roche diagnostics launched the product "Roche’s Tecentriq" with Avastin which was approved by CFDA for the treatment of liver cancer. The outbreak of Covid-19 has impacted IVD products by playing a vital role in the diagnosis of coronavirus symptoms.
This report studies the China IVD Industry and is broken down as follows:
By Segment - The Report Studies the Market of the following 8 Categories:
- Clinical Chemistry
- Immunoassay
- Molecular Testing
- Microbiology
- Hematology
- Self Monitoring of Blood Glucose (SMBG)
- Point of Care Testing (POCT)
- Coagulation
Key Players covered in the report which has been studied from 3 viewpoints:
- Overview
- Initiatives & Recent Developments
- Revenue
Companies covered in this report:
- Roche Diagnostics
- Sysmex Corporation
- Mindray Medical International Limited
- Shanghai Kehua Bio-Engineering Co. Ltd.
- Abbott Laboratories
FEATURED COMPANIES
- Abbott Laboratories
- Roche Diagnostics
- Sysmex Corporation
1. Introduction2. Executive Summary
- Abbott Laboratories
- Mindray Medical International Limited
- Roche Diagnostics
- Shanghai Kehua Bio-Engineering Co. Ltd.
- Sysmex Corporation
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
